Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangdong Cheng

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Annals of Surgical Oncology|April 26, 2026
Impact of Neoadjuvant Chemotherapy on Prognosis of Patients with Mucinous Gastric Adenocarcinoma: A Propensity Score Matching StudyYiming Lu, Danni Zhu, Ke Shen, et al.
Journal of Inflammation Research|July 14, 2022
Pathologic Complete Response Prediction to Neoadjuvant Immunotherapy Combined with Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: Real-World Evidence from Integrative Inflammatory and Nutritional ScoresJifeng Feng, Liang Wang, Xun Yang, et al.
Hepato-Gastroenterology|April 23, 2011
Solid pseudopapillary tumor of the pancreas: clinical analysis of 11 casesPengfei Yu, Xiangdong Cheng, Jianmin Guo, et al.
Journal of Cancer Research and Therapeutics|April 17, 2015
Significance of MDR-related proteins in the postoperative individualized chemotherapy of gastric cancerPengfei Yu, Xiangdong Cheng, Yian Du, et al.
Biomolecules|March 28, 2024
Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer SignalingHaidong Liu, Xiao Li, Yin Shi, et al.
Critical Reviews in Oncology/Hematology|July 3, 2026
Remodeling the Immune Microenvironment: Engineering IL-2 Variants to Overcome Clinical Bottlenecks in PD-1 Inhibitor plus ChemotherapyTing Yang, Yiming Lu, Pengfei Yu, et al.
World Journal of Surgical Oncology|February 8, 2019
Comparison of D2 and D2 plus radical surgery for advanced distal gastric cancer: a randomized controlled studyPengfei Yu, Yian Du, Zhiyuan Xu, et al.
International Immunopharmacology|June 12, 2023
Comprehensive nutritional index predicts clinical outcomes for esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapyJifeng Feng, Liang Wang, Xun Yang, et al.
Annals of Surgical Oncology|October 14, 2023
Pretreatment Pan-Immune-Inflammation Value (PIV) in Predicting Therapeutic Response and Clinical Outcomes of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell CarcinomaJifeng Feng, Liang Wang, Xun Yang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 11, 2024
Clinical significance of geriatric nutritional risk index in esophageal squamous cell carcinoma receiving neoadjuvant immunotherapyJifeng Feng, Liang Wang, Xun Yang, et al.
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Annals of Surgical Oncology|April 26, 2026
Impact of Neoadjuvant Chemotherapy on Prognosis of Patients with Mucinous Gastric Adenocarcinoma: A Propensity Score Matching StudyYiming Lu, Danni Zhu, Ke Shen, et al.
Journal of Inflammation Research|July 14, 2022
Pathologic Complete Response Prediction to Neoadjuvant Immunotherapy Combined with Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: Real-World Evidence from Integrative Inflammatory and Nutritional ScoresJifeng Feng, Liang Wang, Xun Yang, et al.
Hepato-Gastroenterology|April 23, 2011
Solid pseudopapillary tumor of the pancreas: clinical analysis of 11 casesPengfei Yu, Xiangdong Cheng, Jianmin Guo, et al.
Journal of Cancer Research and Therapeutics|April 17, 2015
Significance of MDR-related proteins in the postoperative individualized chemotherapy of gastric cancerPengfei Yu, Xiangdong Cheng, Yian Du, et al.
Biomolecules|March 28, 2024
Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer SignalingHaidong Liu, Xiao Li, Yin Shi, et al.
Critical Reviews in Oncology/Hematology|July 3, 2026
Remodeling the Immune Microenvironment: Engineering IL-2 Variants to Overcome Clinical Bottlenecks in PD-1 Inhibitor plus ChemotherapyTing Yang, Yiming Lu, Pengfei Yu, et al.
World Journal of Surgical Oncology|February 8, 2019
Comparison of D2 and D2 plus radical surgery for advanced distal gastric cancer: a randomized controlled studyPengfei Yu, Yian Du, Zhiyuan Xu, et al.
International Immunopharmacology|June 12, 2023
Comprehensive nutritional index predicts clinical outcomes for esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapyJifeng Feng, Liang Wang, Xun Yang, et al.
Annals of Surgical Oncology|October 14, 2023
Pretreatment Pan-Immune-Inflammation Value (PIV) in Predicting Therapeutic Response and Clinical Outcomes of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell CarcinomaJifeng Feng, Liang Wang, Xun Yang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 11, 2024
Clinical significance of geriatric nutritional risk index in esophageal squamous cell carcinoma receiving neoadjuvant immunotherapyJifeng Feng, Liang Wang, Xun Yang, et al.
Pageof 16